Similar results were obtained in mice treated with a combination of anti-PD-1 antibody and doxorubicin, which led to reduced metastasis of 4T1 mammary tumor, unlike treatment with anti-PD-1 alone [21]. This evidence concerns the gene PDCD1 and breast cancer.